期刊文献+

定量分析鼻咽癌患者外周血游离EBV

Analysis of Cell-Free EBV in Patients with Nasopharyngeal Carcinoma
下载PDF
导出
摘要 目的:分析外周血游离Epstein-Barr病毒(EBV)是否特异地出现于鼻咽癌患者。方法:收集鼻咽癌患者和非鼻咽癌肿瘤患者血浆各50例,正常人血浆30例,提取DNA,荧光定量PCR检测EBV拷贝数,比较游离EBV在上述人群的差异。结果:在25例(50%)鼻咽癌患者血浆中检测到游离EBV,其拷贝数波动于1×103拷贝/ml血浆~2.6×106拷贝/ml血浆,中位数为5.3×105拷贝/ml血浆。在50例非鼻咽癌肿瘤患者和30例正常人血浆中均未检测到游离EBV。结论:游离EBV出现于鼻咽癌患者外周血,可能是一个较特异的鼻咽癌标志物。 Objective:To test whether cell-free EBV occurs specifically in patients with nasopharyngeal carcinoma (NPC).Methods:Plasma specimens were collected from50cases of NPC,50cases of the other tumors rather than NPC and50healthy individuals as control.DNA was prepared and used for detection of EBV by real-time PCR.Results:EBV was detected in25cases of NPC(50%),whereas no EBV was detected in patients with other tumors and healthy donors.Among the cell-free EBV-positive patients,the copies of EBV varied from103to106copies /ml and the median copies were5.3x10copies /ml .Conclusion:Cell-free EBV occurs specifically in NPC patients,it implicates that it may be a useful marker for NPC.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2002年第10期713-715,共3页 Chinese Journal of Clinical Oncology
基金 国家重点基础研究发展规划(973计划)基金资助(G19998051201)
关键词 定量分析 鼻咽癌 外周血 游离EBV NPC EBV Plasma Tumor marker
  • 相关文献

参考文献12

  • 1Huang TB, Wang HM, Li JL, et al. Establishment of high risk population and precancerous lesion of nasopharyngeal carcinoma (NPC). Chinese J Cancer Res, 1997, 9(3): 162~166
  • 2Lo YM, Chan LY, Lo KW, et al. Quantitative analysis of cell-free Epstein-Barr virus in plasma of patients with nasopharyngeal carcinoma. Cancer Res, 1999, 59 (6): 1188~1191
  • 3Lo YM, Chan AT, Chan LY, et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative ananlysis of circulating Epstein-Barr virus DNA. Cancer Res, 2000, 60(24 Suppl): 6878~6881
  • 4Lo YM, Chan LY, Chan AT, et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res, 1999, 59(21): 5452~5455
  • 5Shotelersuk K, Khorprasert C, Sakdikul S, et al. Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer. Clin Cancer Res, 2000, 6(3): 1046~1051
  • 6Mutirangura A, Pomthanakasem W, Theamboonler A, et al. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res, 1998, 4(3): 665~669
  • 7Rickinson AB, Kieff E, Epstein-Barr virus, In: Fields BN, Kinpe DM, Howley PM, et al. (Eds.), Fields Virology, Lippincott-Raven Publishers, Philadephia, 1996:2397~2446
  • 8Khanna R, Moss DJ, Burrows SC. Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation. Immunological Reviews, 1999, 170:49~64
  • 9Khanna R, Busson P, Burrows SR, et al. Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of EpsteinBarr virus cytotoxic T-cell epitopes by NPC cells. Cancer Res, 1998, 58(2): 310~314
  • 10Lee SP, Tierney RJ, Thomas WA, et al. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy, J Immunol, 1997, 158(7): 3325~3334

二级参考文献6

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部